Sensyne Health plc
https://www.sensynehealth.com/
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Sensyne Health plc
Not All AI Companies Are A Success: The Woes Of Sensyne
The business founded by Lord Drayson has struggled to achieve commercial success for its artificial intelligence products.
Spanish Team’s AI Model For Pandemic Response Named XPRIZE Winner
VALENCIA IA4COVID19’s AI model won the XPRIZE Pandemic Response Challenge grand prize. Researchers are pinning their hopes on AI to help predict the next pandemic, but also for early diagnosis of COVID-19.
Digital Health Roundup, January/February 2021: The Continued Rise Of AI, Telehealth
In this new roundup feature focusing on the most notable developments in digital health, we pick the key news from the year so far.
Early-Stage R&D In The Spotlight As BMS Patent Expirations Approach
With the first Revlimid generics launching in 2022, Bristol Myers Squibb’s late-stage assets are key, but earlier programs will help fill the void as Opdivo and Eliquis lose exclusivity later in the decade.
Company Information
- Industry
- Pharmaceuticals
- Services
-
Medical Devices
- Monitoring Equipment & Devices
-
Digital Health
- Artificial Intelligence
-
Biotechnology
-
Drug Discovery Tools
- Bioinformatics
-
Drug Discovery Tools
- Other Names / Subsidiaries
-
- Drayson Health Ltd